[Advances of vasculogenic mimicry in tumors].
Zhang
Shi-wu
SW
Sun
Bao-cun
BC
D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D043168:Angiostatins / Q000494:pharmacology; D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D015820:Cadherins / Q000378:metabolism; D006801:Humans; D061965:Matrix Metalloproteinase Inhibitors; D020782:Matrix Metalloproteinases / Q000378:metabolism*; D055806:Microvessels / Q000378:metabolism; D009369:Neoplasms / Q000098:blood supply* / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000473:pathology*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism; D000099152:Cadherin 5
D020533:Angiogenesis Inhibitors; D043168:Angiostatins; D015703:Antigens, CD; D015820:Cadherins; D061965:Matrix Metalloproteinase Inhibitors; D020782:Matrix Metalloproteinases; D042461:Vascular Endothelial Growth Factor A; D000099152:Cadherin 5